Views & Analysis Rare Youth Project: Can you empower the next generation of r... The next generation of rare disease advocates need a little support in getting their voices heard as part of the Rare Youth Project.
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.